Lipid Nanoparticle and Liposome Reference Materials: Assessment of Size Homogeneity and Long-Term −70 °C and 4 °C Storage Stability

With recent advances and anticipated proliferation of lipid nanoparticle (LNP)-delivered vaccines and therapeutics, there is a need for the availability of internationally recognized reference materials of LNP systems. Accordingly, we developed six LNP and liposome (anionic, neutral, and cationic each) candidate reference material formulations and thoroughly characterized by dynamic light scattering their particle hydrodynamic size (Z-avr) and polydispersity. We also evaluated the particle size homogeneity and long-term −70 °C and 4 °C storage stability using multiple large sets of randomly selected vials for each formulation. The formulations stored at −70 °C remained stable and homogeneous for a minimum of 9 months. The Z-avr relative combined uncertainty and the long-term variability were both <1.3% for liposome formulations and anionic LNPs, (3.9% and 1.7%) for neutral LNPs, and (6.7% and 4.4%) for cationic LNPs. An inadvertent few-hour-long storage temperature increase to −35 °C due to a freezer malfunction resulted in a small change of the size and size distribution of anionic liposomes and LNPs but, unexpectedly, a larger size increase of the neutral and cationic liposomes (≤5%) and LNPs (≤25%). The mean Z-avr values of the LNPs stored at 4 °C appeared to slowly increase with t1/3, where t is the storage time, and the Z-avr between-vial heterogeneity and mean polydispersity index values appeared to decrease; no change was observed for liposomes. The size and size distribution evolution of LNPs stored at 4 °C was attributed to an incomplete equilibration of the formulations following the addition of sucrose prior to the initial freezing. Such a process of size increase and size distribution narrowing has not been previously discussed nor observed in the context of LNPs.

[1]  Z. Jakubek,et al.  Development of lipid nanoparticles and liposomes reference materials (II): cytotoxic profiles , 2022, Scientific Reports.

[2]  A. Zeb,et al.  Formulation optimization, in vitro and in vivo evaluation of agomelatine-loaded nanostructured lipid carriers for augmented antidepressant effects. , 2022, Colloids and surfaces. B, Biointerfaces.

[3]  I. Nowak,et al.  Optimization of the Conditions of Solid Lipid Nanoparticles (SLN) Synthesis , 2022, Molecules.

[4]  Márcia Renata Mortari,et al.  Therapeutic nanoparticles in the brain: a review of types, physicochemical properties and challenges. , 2021, International journal of pharmaceutics.

[5]  Carlos R. Baiz,et al.  Molecular Mechanism of Cell Membrane Protection by Sugars: A Study of Interfacial H-Bond Networks. , 2021, The journal of physical chemistry letters.

[6]  R. Langer,et al.  Lipid nanoparticles for mRNA delivery , 2021, Nature Reviews Materials.

[7]  Q. Zhou,et al.  Lipid Nanoparticles-From Liposomes to mRNA Vaccine Delivery, a Landscape of Research Diversity and Advancement. , 2021, ACS nano.

[8]  B. Leavitt,et al.  The current landscape of nucleic acid therapeutics , 2021, Nature Nanotechnology.

[9]  R. Cortesi,et al.  Challenges in the Physical Characterization of Lipid Nanoparticles , 2021, Pharmaceutics.

[10]  F. Caputo,et al.  Improved multidetector asymmetrical-flow field-flow fractionation method for particle sizing and concentration measurements of lipid-based nanocarriers for RNA delivery. , 2021, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[11]  W. Jiskoot,et al.  Addressing the Cold Reality of mRNA Vaccine Stability , 2020, Journal of Pharmaceutical Sciences.

[12]  M. Marioli,et al.  Analytical characterization of liposomes and other lipid nanoparticles for drug delivery. , 2020, Journal of pharmaceutical and biomedical analysis.

[13]  Amelia Carolina Sparavigna,et al.  The Ice-Water Interface and Protein Stability: A Review. , 2020, Journal of pharmaceutical sciences.

[14]  Yizhou Dong,et al.  Long-term storage of lipid-like nanoparticles for mRNA delivery , 2020, Bioactive materials.

[15]  M. Manoharan,et al.  The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs , 2019, Nature Nanotechnology.

[16]  M. R. Mozafari,et al.  Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems , 2018, Pharmaceutics.

[17]  P. Cullis,et al.  Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[18]  Jiří Damborský,et al.  Suppression of protein inactivation during freezing by minimizing pH changes using ionic cryoprotectants. , 2016, International journal of pharmaceutics.

[19]  A. Roy,et al.  A Comparative Study of the Influence of Sugars Sucrose, Trehalose, and Maltose on the Hydration and Diffusion of DMPC Lipid Bilayer at Complete Hydration: Investigation of Structural and Spectroscopic Aspect of Lipid-Sugar Interaction. , 2016, Langmuir : the ACS journal of surfaces and colloids.

[20]  H. Ishihara,et al.  siRNA-lipid nanoparticles with long-term storage stability facilitate potent gene-silencing in vivo. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[21]  S. Moghimi,et al.  Recent Advances in Cryo-TEM Imaging of Soft Lipid Nanoparticles , 2015 .

[22]  Marian E. Gindy,et al.  Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics. , 2014, Molecular pharmaceutics.

[23]  J. Vollmer,et al.  Ripening and focusing of aggregate size distributions with overall volume growth , 2014, Front. Physics.

[24]  Wolfgang Friess,et al.  The freezing step in lyophilization: physico-chemical fundamentals, freezing methods and consequences on process performance and quality attributes of biopharmaceuticals. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[25]  R. Bhandari,et al.  Potential of solid lipid nanoparticles in brain targeting. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[26]  S. Badawy,et al.  Microenvironmental pH modulation in solid dosage forms. , 2007, Journal of pharmaceutical sciences.

[27]  R. Hidalgo-Álvarez,et al.  Size and stability of liposomes: A possible role of hydration and osmotic forces , 2006, The European physical journal. E, Soft matter.

[28]  A. Morfesis,et al.  High Resolution Zeta Potential Measurements: Analysis of Multi-component Mixtures , 2002 .

[29]  M. Kahlweit,et al.  Ostwald ripening of precipitates , 1975 .